CAS: 1418205-77-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Bimekizumab REF: 3D-CLA1350CAS: 1418205-77-2 | - - - | To inquire | Thu 12 Dec 24 |
 | Bimekizumab REF: TM-T76798CAS: 1418205-77-2 | - - - | 347.00 €~1,146.00 € | Tue 21 Jan 25 |
Bimekizumab
CAS:1418205-77-2
Humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody; plaque psoriasis and psoriatic arthritis treatment
Ref: 3D-CLA1350
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
Bimekizumab
CAS:1418205-77-2
Bimekizumab, a humanized antibody, selectively neutralizes IL-17A/F, blocking inflammation-driven osteogenic differentiation.
Color and Shape:
Liquid
Ref: TM-T76798
| 1mg | 347.00 € | ||
| 5mg | 734.00 € | ||
| 10mg | 1,146.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
